Median HDL cholesterol concentrations (and ranges) (mmol/l) before and after treatment with cimetidine or ranitidine with ranitidine, and concentrations of HDL and HDL3 cholesterol were not significantly different after treatment with cimetidine.
Overall, 31 (12 4%) had clearly positive ratios (> 5 0) and a further 30 (12 0%) had borderline ratios (3 0-<5 0). Western blots of serum samples from subjects with antibodies yielded bands consistent with HTLV-III as found in American patients with AIDS and members of groups at risk of AIDS. The prevalence of antibody was highest in childhood (p-002); among adults prevalence rose slightly with age. HTLV-III antibodies were more common among the uneducated (p-0006), agricultural workers (p=0 03), and rural residents (p=0 06), but the Western blot bands were generally weak in this group. By contrast, one urban resident had strong bands.
The relatively high prevalence of antibodies among the rural poor in this area of Zaire suggests that HTLV-III or a closely related, cross reactive virus may be endemic in the region. A different natural history of infection, perhaps in childhood, may also explain the findings. Introduction Investigators have recently described a retrovirus that appears to be a causative for acquired immunodeficiency syndrome (AIDS).'-4 This agent, a member of the human T cell lymphotropic virus (HTLV) family, has repeatedly been isolated from American and European patients with AIDS and subjects at risk of AIDS, most of whom also had detectable antibody against the agent.5 6 Prospective studies have confirmed that those with antibodies are more likely to develop AIDS.7 8 By contrast, fewer than 10/ of healthy American blood donors have antibodies to the agent.5 8a AIDS has also been described in Africans'-13 and in Europeans who had a history of travel in Africa but no other risk 16 MARCH 1985 factors. ' Western blots detected antibodies against HTLV-III viral components in eight out of eight subjects with ratios of greater than 10 0, four of six subjects with ratios of greater than 5 0, and one of nine subjects with ratios of less than 3 0. The subject with the highest ratio (21 5 ) was a 20 year old woman student from Bukavu who presented with acute onset gastroenteritis. In this patient the pattern of Western blotting was strongly positive for all the bAnds seen in patients with AIDS (p24, p41, p61). In the other subjects bands were relatively weak.
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The origins of a virus causing AIDS have been the subject of considerable speculation. Several investigators have suggested an African origin. Favouring this hypothesis are the reports of cases among Europeans with histories of travel to Africa well before the AIDS epidemic'4 1" and the recognition of African cases with no admitted connection to groups at risk of the disease.9 -13 Arguing that the AIDS agent is new in Africa was the sudden appearance of African cases in Europe only in 1980 and later,'0 temporally coincident with the AIDS epidemic in the United States rather than earlier. Moreover, African cases in Africa appear to be increasing in a manner parallel to that of epidemic AIDS in America and Europe.'2 13 Finally, a recent report suggested that Kaposi's sarcoma of the aggressive variety -a form often seen among homosexual men with AIDS in America and Europe-suddenly became epidemic in Zambia in 1983."0 Kaposi's sarcoma is endemic in this region of Zaire, but no change in the incidence or type of Kaposi's sarcoma has been observed at FOMULAC Hospital, and the cases of Kaposi's sarcoma were not associated with HTLV-III. la None of the cases seen at FOMULAC Hospital showed features suggestive of the epidemic, aggressive cases of the type described in Zambia. 2 We found a high prevalence of antibodies against HTLV-III in this remote, rural population of eastern Zaire, which, if provoked by infection with HTLV-III, suggests that HTLV-III is unlikely to be new in this part of Africa. Factors influencing the likelihood of seropositivity were lack of education, agricultural employment, and rural residence, all suggesting that seropositivity is more common among the rural poor. In addition, people of lower weight appeared more likely to be seropositive, and if lower weight is a function of poverty in this environment it may be that the poorer of the poor are most at risk.
While antibodies against HTLV-III appear to be relatively common in this population, AIDS like illness has not been diagnosed. Recognition of AIDS among Africans may be limited, however, because of lack of experience with the range of clinical manifestations that this disease may have in areas with different opportunistic infections and in subjects infected at a young age. African cases have generally been in adults with the types of infection also seen among Europeans and Americans with RIDS. At FOMULAC Hospital no case of AIDS has ever been identified, although patients in two of the cases identified in Kinshasa were said to have come from Bukavu (de Feyter, personal information). Among the subjects with antibodies in this survey there was no correlation with any symptoms of illness or acute or non-acute health complaints, suggesting that these subjects were not ill with any of the AIDS related health problems described in current epidemics at the time of the survey. Thus if antibodies indicate prior exposure to HTLV-III, this population must have had and survived HTLV-III infection without lasting health problems.
There are several possible explanations. The greater prevalence of HTLV-III among children in this study might support a hypothesis in which the adult population has been exposed to HTLV-III infection in childhood, with some of the children who were infected being lost from the study population. An extension would be that the influx of an infected rural population (adapted biologically to the virus) into an urban area with a pool of susceptible, more affluent adults created new opportunities for the virus to cause illness in urban adults and the epidemic appearance of the disease in Africa. Many of the recognised cases have been in noticeably wealthy people, although this may well be a function of better access to medical facilities and diagnosis. In this regard the 20 year old student with strong bands on Western blots may be an example of a recently infected urban resident, whereas those with weaker bands, generally rural residents, may have had infection long before. In a setting of high mortality in childhood, particularly from infectious diseases, cases of AIDS in children may well go unrecognised.
The possibility of non-specific results must be considered, since a high frequency of non-confirmed ELISA positivity against a related human retrovirus, HTLV-I, was found in subjects from Ghana, west Africa.22 Nevertheless, the correlation between Western blotting and ELiSA results for HTLV-III in this study was excellent. The bands observed in these cases were generally weak, but they did correspond to proteins of the size and characteristics of the HITLV-III antigens precipitated by AIDS and seen in patients at risk of AIDS. This reactivity suggests that the provoking agent was HTLV-III or a highly cross reactive virus.
With regard to the latter possibility, the assay may be measuring responses to a similar and cross reactive virus that does not have the pathogenicity of the AIDS related HTLV-III. Such a virus might be the ancestor from which a new variant, pathogenic AIDS related HTLV-III, has recently mutated, or it might be another new member of the family of human retroviruses. Isolation and characterisation of the agent from healthy members of this population will be necessary to compare it with the virus causing AIDS.
